Idorsia Ltd (XSWX:IDIA)
CHF 2.27 0.146 (6.87%) Market Cap: 408.69 Mil Enterprise Value: 1.43 Bil PE Ratio: 16.34 PB Ratio: 0 GF Score: 52/100

Idorsia Ltd at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 - Jan 12, 2023 / NTS GMT
Release Date Price: CHF14.43 (+2.49%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the Idorsia presentation. So you're going to hear from Idorsia CEO, Jean-Paul Clozel, and we have about a 20-minute presentation, and then we'll have 15, 20 minutes for your questions, which we're going to take in the same room. So with that said, thanks very much for joining us today, Jean-Paul, looking forward to the presentation.

Jean;Paul Clozel
Idorsia Ltd - CEO & Executive Director

Thank you. You just have swallowed 30 seconds from the presentation. Okay. So good afternoon, everybody. I think Idorsia -- for Idorsia, the year 2023 is going to be really very interesting. And this is really because of all the work, and after this disclaimer, because of all the work that we did in 2022. And in this 2022 year, we achieved a lot.

We achieved a lot because we became a commercial company. Idorsia launched QUVIVIQ,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot